microdose of tirzepatide (Injections) – Immortals 3- Month Micro-dosing Tirzepatide |

Indias pharma market grew 7.3% YoY in September, led by strong demand in antidiabetic, cardiac, and respiratory segments

Although these drugs were initially developed for the treatment of type 2 diabetes, clinical studies have largely demonstrated their beneficial effects in metabolic, renal, and cardiovascular diseases that go beyond glucose control (Minze et al., 2018

In a 2023 survey by Everyday Health with more than 3,000 participants, those who lost weight were about twice as likely to have tried these drugs as people who maintained or gained weight

Your antenatal team will discuss whether anything else is needed based on your wider clinical picture

While single-dose or short-term studies may demonstrate acceptable safety, the long-term consequences of daily or weekly tissue penetration over years of chronic therapy remain to be characterized